Regenerative medicine: Then and now - an update of recent history into future possibilities

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 10, 2010, Pages 2350-2358

  Polykandriotis, E ^a   Popescu, L M ^b,c   Horch, R E ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Medical Genetics 'Victor Babes'   (Romania)

^c CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Biomaterials; Cell therapies; Economics; Genetical engineering; History; Regenerative medicine; Stem cells; Tissue engineering

Indexed keywords

BIOMATERIAL;

ARTICLE; BIOLOGICAL THERAPY; BIOTECHNOLOGY; GENETIC ENGINEERING; HISTORY; HUMAN; REGENERATIVE MEDICINE; STEM CELL; TISSUE ENGINEERING;

BIOCOMPATIBLE MATERIALS; BIOTECHNOLOGY; GENETIC ENGINEERING; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; REGENERATIVE MEDICINE; STEM CELLS; TISSUE ENGINEERING; TISSUE THERAPY;

GAMOCHAETA;

EID: 77958585776     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01169.x     Document Type: Article

References (82)

1. nd ed. New York: Charles Scribner's Sons; 1905. 284 p.
2. Daar AS, Greenwood HL. A proposed definition of regenerative medicine. J Tissue Eng Regen Med. 2007; 1: 179-84.
3. Zhang H, Lau SF, Heng BF, et al Generation of easily accessible human kidney tubules on two-dimensional surfaces in vitro. J Cell Mol Med. 2010; Doi: 10.1111/j.1582-4934.2010.01113.x
4. Spadaccio C, Rainer A, Trombetta M, et al A G-CSF functionalized scaffold for stem cells seeding: a differentiating device for cardiac purposes. J Cell Mol Med. 2010; Doi: 10.1111/j.1582-4934.2010.01100.x.
5. Gaetani R, Rizzitelli G, Chimenti I, et al Cardiospheres and tissue engineering for myocardial regeneration: potential for clinical application. J Cell Mol Med. 2010; 14: 1071-7.
6. Choi YS, Dusting GJ, Stubbs S, et al Differentiation of human adipose-derived stem cells into beating cardiomyocytes. J Cell Mol Med. 2010; 14: 878-89.
7. Langer R, Vacanti JP. Tissue engineering. Science. 1993; 260: 920-6.
8. Buchanan IM, Scott T, Tandle AT, et al Radiosensitization of glioma cells by modulation of Met signaling with the hepatocyte growth factor neutralizing antibody, AMG102. J Cell Mol Med. 2010; Doi: 10.1111/j.1582-4934.2010.01122.x.
9. Pneumaticos SG, Triantafyllopoulos GK, Basdra EK, et al Segmental bone defects: from cellular and molecular pathways to the development of novel biological treatments. J Cell Mol Med. 2010; Doi: 10.1111/j.1582-4934.2010.01062.x.
10. Wang H, Zhou J, Liu Z, et al Injectable cardiac tissue engineering for the treatment of myocardial infarction. J Cell Mol Med. 2010; 14: 1044-55.
11. Mollmann H, Nef HM, Voss S, et al Stem cell-mediated natural tissue engineering. J Cell Mol Med. 2009; Doi: 10.1111/j.1582-4934.2009.00972.x.
12. Ballyns JJ, Bonassar LJ. Image-guided tissue engineering. J Cell Mol Med. 2009; 13: 1428-36.
13. Nesselmann C, Ma N, Bieback K, et al Mesenchymal stem cells and cardiac repair. J Cell Mol Med. 2008; 12: 1795-810.
14. Fiegel HC, Pryymachuk G, Rath S, et al Foetal hepatocyte transplantation in a vascularized AV-Loop transplantation model in the rat. J Cell Mol Med. 2010; 14: 267-74.
15. Kroehne V, Heschel I, Schugner F, et al Use of a novel collagen matrix with oriented pore structure for muscle cell differentiation in cell culture and in grafts. J Cell Mol Med. 2008; 12: 1640-8.
16. Eyden B. The myofibroblast: phenotypic characterization as a prerequisite to understanding its functions in translational medicine. J Cell Mol Med. 2008; 12: 22-37.
17. Horch RE. Future perspectives in tissue engineering. J Cell Mol Med. 2006; 10: 4-6.
18. Horch RE, Kopp J, Kneser U, et al Tissue engineering of cultured skin substitutes. J Cell Mol Med. 2005; 9: 592-608.
19. Boos AM, Loew JS, Deschler G, et al Directly auto-transplanted mesenchymal stem cells induce bone formation in a ceramic bone substitute in an ectopic sheep model. J Cell Mol Med. 2010; Doi: 10.1111/j.1582-4934.2010.01131.x.
20. Kong LM, Liao CG, Chen L, et al Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma. J Cell Mol Med. 2010; Doi: 10.1111/j.1582-4934.2010.01124.x.
21. Lu S, Li Y, Liu S, et al Engineered heart tissue graft derived from somatic-cell-nuclear-transferred embryonic stem cells improve myocardial performance in infarcted rat heart. J Cell Mol Med. 2010; Doi: 10.1111/j.1582-4934.2010.01112.x.
22. Satija NK, Singh VK, Verma YK, et al Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine. J Cell Mol Med. 2009; 13: 4385-402.
23. Jiang F, Zhang G, Hashimoto I, et al Neovascularization in an arterio-venous loop-containing tissue engineering chamber: role of NADPH oxidase. J Cell Mol Med. 2008; 12: 2062-72.
24. Steffens L, Wenger A, Stark GB, et al In vivo engineering of a human vasculature for bone tissue engineering applications. J Cell Mol Med. 2009; 13: 3380-6.
25. Vacanti CA. The history of tissue engineering. J Cell Mol Med. 2006; 10: 569-76.
26. Hutmacher DW, Horch RE, Loessner D, et al Translating tissue engineering technology platforms into cancer research. J Cell Mol Med. 2009; 13: 1417-27.
27. Mason C. The time has come to engineer tissues and not just tissue engineer. Regen Med. 2006; 1: 303-6.
28. Aeschylus. Prometheus bound. Athens: Patakis, 415 B.C.
29. Rosenthal N. Prometheus's vulture and the stem-cell promise. N Engl J Med. 2003; 349: 267-74.
30. Aristotle. The complete works: the revised Oxford edition. Princeton, NJ: Princeton University Press; 1984.
31. Genesis. I:1. Wheaton: Crossway Publications; pp. 21-2.
32. Matthews LG. SS. Cosmas and Damian - patron saints of medicine and pharmacy their cult in England. Med Hist. 1968; 12: 281-8.
33. Asenjo A. Neurosurgical techniques. Springfield: Charles C Thomas; 1963.
34. Dinsmore E. A history of regeneration research: milestones in the evolution of a science. Cambridge: Cambridge University Press; 1991.
35. Coleman W. Biology in the nineteenth century: problems of form, function and transformation. 2nd ed. Cambridge: Cambridge University Press; 1978.
36. Stocum D. An overview of regenerative biology and medicine. Regenerative biology and medicine. 1st ed. Oxford: Academic Press; 2006. pp. 1-20.
37. Wohlrab F, Henoch U. The life and work of Carl Weigert (1845-1904) in Leipzig 1878-1885. Zentralbl Allg Pathol. 1988; 134: 743-51.
38. Barth A. Ueber histologische Befunde nach Knochenimplantationen. Arch Klin Chir. 1893; 46: 409-17.
39. Leff D. New biological assembly line. The cell: interand intra-relationships. New Jersey: Avery Publishing Group; 1983.
40. Hayflick L. Entropy explains aging, genetic determinism explains longevity, and undefined terminology explains misunderstanding both. PLoS Genet. 2007; 3: e220.
41. Kleinsmith LJ, Pierce GB Jr. Multipotentiality of single embryonal carcinoma cells. Cancer Res. 1964; 24: 1544-51.
42. Papaioannou VE, McBurney MW, Gardner RL, et al Fate of teratocarcinoma cells injected into early mouse embryos. Nature. 1975; 258: 70-3.
43. Damjanov I. Teratocarcinoma: neoplastic lessons about normal embryogenesis. Int J Dev Biol. 1993; 37: 39-46.
44. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA. 1981; 78: 7634-8.
45. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981; 292: 154-6.
46. Thomson JA, Kalishman J, Golos TG, et al Pluripotent cell lines derived from common marmoset (Callithrix jacchus) blastocysts. Biol Reprod. 1996; 55: 254-9.
47. Andrews PW. Human teratocarcinomas. Biochim Biophys Acta. 1988; 948: 17-36.
48. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282: 1145-7.
49. Bell E, Ehrlich HP, Buttle DJ, et al Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science. 1981; 211: 1052-4.
50. Lysaght MJ, Crager J. Origins. Tissue Eng A. 2009; 15: 1449-50.
51. Skalak R, Fox C. Tissue engineering. Proceedings of a workshop held at Granlibakken, Lake Tahoe, California. New York: Liss; 1989.
52. Time Magazine. What will be the 10 hottest jobs? Accessed September 20, 2009.
53. Kemp P. History of regenerative medicine: looking backwards to move forwards. Regen Med. 2006; 1: 653-69.
54. Lysaght MJ, Hazlehurst AL. Tissue engineering: the end of the beginning. Tissue Eng. 2004; 10: 309-20.
55. Wilmut I, Schnieke AE, McWhir J, et al Viable offspring derived from fetal and adult mammalian cells. Nature. 1997; 385: 810-3.
56. Beier JP, Klumpp D, Rudisile M, et al Collagen matrices from sponge to nano: new perspectives for tissue engineering of skeletal muscle. BMC Biotechnol. 2009; 9: 34.
57. Manetti M, Guiducci S, Ibba-Manneschi L, et al Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis. J Cell Mol Med. 2010; 14: 1241-54.
58. Vacanti JP, Langer R, Upton J, et al Transplantation of cells in matrices for tissue regeneration. Adv Drug Deliv Rev. 1998; 33: 165-82.
59. Mooney DJ, Mikos AG. Growing new organs. Sci Am. 1999; 280: 60-5.
60. Polykandriotis E, Euler S, Arkudas A, et al Regression and persistence: remodelling in a tissue engineered axial vascular assembly. J Cell Mol Med. 2009; 13: 4166-75.
61. Polykandriotis E, Arkudas A, Horch RE, et al Autonomously vascularized cellular constructs in tissue engineering: opening a new perspective for biomedical science. J Cell Mol Med. 2007; 11: 6-20.
62. Polykandriotis E, Tjiawi J, Euler S, et al The venous graft as an effector of early angiogenesis in a fibrin matrix. Microvasc Res. 2008; 75: 25-33.
63. Booth BL. Beyond the biotech IPO: a brave new world. Nat Biotechnol. 2009; 27: 705-9.
64. Fenn J, Raskino M. Mastering the hype cycle: how to choose the right innovation at the right time. Boston: Mcgraw-Hill Professional; 2008.
65. EurActiv.com PLC. Biotech start-ups turn to US for finance. Accessed June 28, 2010.
66. Auerswald P, Branscomb L. Valleys of death and Darwinian seas: financing the invention to innovation transition in the United States. J Technol Transfer. 2003; 28: 227-39.
67. Brindley D, Davie N. Regenerative medicine through a crisis: social perception and the financial reality. Rejuvenation Res. 2009; 12: 455-61.
68. Pirraco RP, Marques AP, Reis RL. Cell interactions in bone tissue engineering. J Cell Mol Med. 2010; 14: 93-102.
69. Swetha G, Chandra V, Phadnis S, et al Glomerular parietal epithelial cells of adult murine kidney undergo EMT to generate cells with traits of renal progenitors. J Cell Mol Med. 2009; DOI: 10.1111/j.1582-4934.2009.00937.x
70. Chen Y, Xiang LX, Shao JZ, et al Recruitment of endogenous bone marrow mesenchymal stem cells towards injured liver. J Cell Mol Med. 2010; 14: 1494-508.
71. Cotten M, Fisher K. Autologous cord blood cells for hypoxic ischemic encephalopathy study 1. Phase I study of feasibility and safety. North Carolina: Duke University; 2008.
72. Haller MJ, Wasserfall CH, McGrail KM, et al Autologous umbilical cord blood transfusion in very young children with type 1 diabetes. Diabetes Care. 2009; 32: 2041-6.
73. Vendrame M, Gemma C, De Mesquita D, et al Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev. 2005; 14: 595-604.
74. Revoltella RP, Papini S, Rosellini A, et al Cochlear repair by transplantation of human cord blood CD133+ cells to nod-scid mice made deaf with kanamycin and noise. Cell Transplant. 2008; 17: 665-78.
75. Bergmann O, Bhardwaj RD, Bernard S, et al Evidence for cardiomyocyte renewal in humans. Science. 2009; 324: 98-102.
76. Kostin S. Myocardial telocytes: a specific new cellular entity. J Cell Mol Med. 2010; Doi: 10.1111/j.1582-4934.2010.01111.x.
77. Gherghiceanu M, Popescu LM. Cardiomyocyte precursors and telocytes in epicardial stem cell niche: electron microscope images. J Cell Mol Med. 2010; 14: 871-7.
78. Popescu LM, Faussone-Pellegrini MS. TELOCYTES - a case of serendipity: the winding way from interstitial cells of Cajal (ICC), via interstitial Cajal-like cells (ICLC) to TELOCYTES. J Cell Mol Med. 2010; 14: 729-40.
79. Kupcsik L, Meurya T, Flury M, et al Statin-induced calcification in human mesenchymal stem cells is cell death related. J Cell Mol Med. 2009; 13: 4465-73.
80. Eyckmans J, Roberts SJ, Schrooten J, et al A clinically relevant model of osteoinduction: a process requiring calcium phosphate and BMP/Wnt signalling. J Cell Mol Med. 2010; 14: 1845-56.
81. Van Osch GJ, Brittberg M, Dennis JE, et al Cartilage repair: past and future - lessons for regenerative medicine. J Cell Mol Med. 2009; 13: 792-810.
82. Bani D, Formigli L, Gherghiceanu M, et al Telocytes as supporting cells for myocardial tissue organization in developing and adult heart. J Cell Mol Med. 2010; 14: 2531-9.